Control of Tumor Progression by Angiocrine Factors

Simple Summary The growth of a solid malignant tumor mass depends on the formation of new blood vessels by endothelial cells. However, endothelial cells do not only provide conduits for blood transportation, but also express numerous factors which promote the aggressiveness of cancer cells, influence the immune response toward cancer cells and thereby contribute to tumor progression and metastasis. This Review provides a comprehensive overview about such angiocrine factors and how they orchestrate the tumor microenvironment. Tumor progression, therapy resistance and metastasis are profoundly controlled by the tumor microenvironment. The contribution of endothelial cells to tumor progression was initially only attributed to the formation of new blood vessels (angiogenesis). Research in the last decade has revealed however that endothelial cells control their microenvironment through the expression of membrane-bound and secreted factors. Such angiocrine functions are frequently hijacked by cancer cells, which deregulate the signaling pathways controlling the expression of angiocrine factors. Here, we review the crosstalk between cancer cells and endothelial cells and how this contributes to the cancer stem cell phenotype, epithelial to mesenchymal transition, immunosuppression, remodeling of the extracellular matrix and intravasation of cancer cells into the bloodstream. We also address the long-distance crosstalk of a primary tumor with endothelial cells at the pre-metastatic niche and how this contributes to metastasis.

Automated summary

Endothelial cells play a crucial role in promoting cancer cell aggressiveness, influencing immune response, and contributing to tumor progression and metastasis through the expression of angiocrine factors. The crosstalk between cancer cells and endothelial cells contributes to various processes including cancer stem cell phenotype, epithelial to mesenchymal transition, immunosuppression, ECM remodeling, and intravasation of cancer cells into the bloodstream, ultimately impacting tumor progression and metastasis.